Silymarin: What is in the name…? An appeal for a change of editorial policy
- 1 August 2000
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 32 (2), 442-444
- https://doi.org/10.1053/jhep.2000.9770
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Significant inhibition by the flavonoid antioxidant silymarin against 12-O-tetradecanoylphorbol 13-acetate-caused modulation of antioxidant and inflammatory enzymes, and cyclooxygenase 2 and interleukin-1? expression in SENCAR mouse epidermis: Implications in the prevention of stage I tumor promotionMolecular Carcinogenesis, 1999
- Herbal products for liver diseases: A therapeutic challenge for the new millenniumHepatology, 1999
- Activities of silymarin and its flavonolignans upon low density lipoprotein oxidizability in vitroPhytotherapy Research, 1999
- Milk Thistle ( Silybum marianum ) for the Therapy of Liver DiseaseAmerican Journal Of Gastroenterology, 1998
- Effect of antifibrotic agent silymarin on liver cell regeneration in a rat model of secondary biliary fibrosis: a morphometric analysisPhytotherapy Research, 1998
- Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in ratsHepatology, 1997
- Glycosylation of silybinJournal of the Chemical Society, Perkin Transactions 1, 1997
- Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activityBritish Journal of Cancer, 1996
- Two high-performance liquid chromatographic assays for the determination of free and total silibinin diastereomers in plasma using column switching with electrochemical detection and reversed-phase chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1995
- Evaluation of the silymarin content in Silybum marianum (L.) Gaertn. Cultivated under different agricultural conditionsPhytotherapy Research, 1993